AASLD expects more than 9500 hepatologists and hepatology health professionals from all over the world to exchange the latest liver disease research, discuss treatment outcomes and networking with colleagues.
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
No comments:
Post a Comment